Faraday Pharmaceuticals

Faraday Pharmaceuticals is a developer of novel therapeutic agents based on Elemental Reducing Agents (ERAs). The company's treatments focus on the ability of specific reduced forms of elements to improve patient outcomes, enabling healthcare practitioners to address ischemia-reperfusion injury and other critical care conditions in a streamlined manner.